Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - BIOFIELD CORP \DE\c95250exv32w2.htm
EX-31.2 - EXHIBIT 31.2 - BIOFIELD CORP \DE\c95250exv31w2.htm
EX-32.1 - EXHIBIT 32.1 - BIOFIELD CORP \DE\c95250exv32w1.htm
EX-31.1 - EXHIBIT 31.1 - BIOFIELD CORP \DE\c95250exv31w1.htm
 
 
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 2
to

FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2009
Commission File No: 0-27848
BIOFIELD CORP.
(Name of registrant in its charter)
     
Delaware   13-3703450
(State of other jurisdiction of Incorporation or Organization)   (Employer Identification Number)
     
175 Strafford Avenue, Suite 1, Wayne, PA   19087
(Address of principal executive offices)   (Zip Code)
(215) 972-1717
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 30 days: Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No þ
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of accelerated filer and large accelerated filer in Rule 12b-12 of the Exchange Act (Check one):
             
Large Accelerated Filer
  o   Accelerated Filer   o
Non-Accelerated Filer
  o   Smaller Reporting Company   þ
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Yes o No þ
AS OF NOVEMBER 13, 2009, THERE WERE 36,261,833 SHARES OF COMMON STOCK OUTSTANDING AND 12,300,000 SHARES OF VOTING PREFERRED STOCK OUTSTANDING.
 
 

 

 


 

EXPLANATORY NOTE
Biofield Corp. (the “Company”) is filing this Amendment No. 2 to its Quarterly Report on Form 10-Q/A for the quarter ended September 30, 2009, which was originally filed with the Securities and Exchange Commission (“SEC”) on November 20, 2009 (the “original Form 10-Q”), to include new certifications as exhibits 31.1, 31.2, 32.1 and 32.2 by our principal executive officer and principal financial officer as required by Rules 12b-15 and 13a-14 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
Except for the amended disclosures and reclassification described above, the information in this Form 10-Q/A has not been updated to reflect events that occurred after November 20, 2009, the filing date of our original Form 10-Q. Accordingly, this Form 10-Q/A should be read in conjunction with our filings made with the SEC subsequent to the filing of the original Form 10-Q, including any amendments to those filings.

 

 


 

SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, there unto duly authorized.
         
  BIOFIELD CORP.
 
 
Date: February 1, 2010  By:   /s/ David Bruce Hong    
    David Bruce Hong   
    Chief Executive Officer   
 
     
  By:   /s/ David Bruce Hong    
    David Bruce Hong   
    Chief Financial Officer